$12.67
-0.24-1.86%
At close: -
$12.67
0.000.00%
After Hours: Jan 31, 4:00 PM EDT
Myriad Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Myriad Genetics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $0.06 | $0.02 | 200.0 % |
Q2 | 2024-08-06 | $0.05 | $-0.01 | 600.0 % |
Q1 | 2024-05-07 | $-0.01 | $-0.10 | 90.0 % |
Q4 | 2024-02-27 | $0.04 | $0.01 | 300.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $213.30M | $210.73M | 1.22 % |
Q2 | 2024-08-06 | $211.50M | $204.95M | 3.20 % |
Q1 | 2024-05-07 | $202.20M | $193.26M | 4.63 % |
Q4 | 2024-02-27 | $196.60M | $194.78M | 0.93 % |
Myriad Genetics (MYGN) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $0.06, which beat the estimate of $0.02.
The Actual Revenue was $213.3M, which beat the estimate of $210.7M.
Browse earnings estimates, EPS, and revenue on all stocks.